The health tech startup Motif Neurotech has secured nearly $19 million in a series A funding round. The company, which develops minimally invasive bioelectronics for mental health treatment, was formed out of the Rice Biotech Launch Pad at Rice University. The funding will be used to develop the company’s inaugural product, the DOT microstimulator, which aims to provide at-home therapy for treatment-resistant depression. The round was led by Arboretum Ventures and included participation from several other investors. Tom Shehab from Arboretum Ventures and Amy Kruse from Satori Neuro will join Motif Neurotech’s board of directors.
$19M Series A Funding Secured by Rice University Medical Device Spinout
Latest from Blog
Venture Capital Boom: AI Startups Revolutionizing Healthcare Funding
TLDR: Healthcare AI startups have raised about $60 billion in venture capital funding over the past decade. Only over 5% of companies selling to health systems have matured beyond seed and early-stage
Decrease in Private Market Funding in Second Quarter
TLDR: Bloomberg article addresses the issue of unusual activity detection in computer networks. Readers are prompted to confirm they are not robots by clicking a box. Bloomberg recently published an article discussing
Impact Founder’s $250M Raise: VC Insight and Outlook
TLDR: Key Points: Bloomberg article addressing unusual activity detection on computer networks prompting users to verify they are not robots. Inquiries related to the message can be directed to the support team
Top 10 Biotech and AI Funding Rounds of the Week
TLDR: Big week for biotech and AI funding rounds Top 10 funding rounds highlighted The past week saw significant funding rounds in the biotech and AI sectors, with two notable nine-figure rounds
AI Startup World Labs Secures $230M Funding from Top Investors
TLDR: – AI startup World Labs launched with over $230 million in total funding led by Andreessen Horowitz, NEA, and Radical Ventures. – Co-founded by Fei-Fei Li, World Labs aims to enhance
